查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1258198

2022-2029 年全球血漿蛋白治療市場規模研究與預測按產品類型,應用和地區分析

Global Plasma Protein Therapeutics Market Size study & Forecast, by Product Type, by Application and Regional Analysis, 2022-2029
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3個工作天內

價格

2021 年全球血漿蛋白治療市場價值約為 274,5 億美元，預計在 2022-2029 年預測期內將以超過 7% 的健康增長率增長。

血漿蛋白製品是由血漿組成的生物藥品。 血漿是一種生物材料，根據其製造和加工方式的不同，其化學成分也不同。 血液主要由血漿組成，含有水,鹽,蛋白質,抗體和□。 由於免疫缺陷病發病率增加和老年人口快速增長等因素，血漿蛋白市場正在擴大。 由於免疫缺陷疾病增加和人口老齡化等因素，血漿蛋白市場正在擴大。

血漿蛋白用於治療各種慢性,危及生命和遺傳性疾病。 它的受歡迎程度在過去幾年中逐漸增加。 據 Statista 稱，到 2020 年，全球血漿需求預計將增長 5000 萬升。 此外，到 2020 年，全球將消耗 1018,8 公噸白蛋白，預計到 2022 年將達到約 1125,5 公噸。 它是世界上用於癌症診斷和治療的血漿產生的蛋白質，以及莫布斯·威爾遜的治療方法。 主要用於癌症的診斷和治療。 推動空間增長的另一個關鍵因素是不斷增長的老齡化人口。 到 2022 年，摩納哥 65 歲及以上人口占總人口的比例將最高。 摩納哥是世界上人口老齡化速度最快的國家，其中 36% 的日本人超過 65 歲。 到 2022 年，德國將有 22% 的人口超過 65 歲。 世界上大約 25% 的人口年齡在 15 歲以下，10% 的人口年齡在 65 歲以上。 世界上最年輕的人口在非洲。 許多國家的預期壽命也很低，40% 的人口年齡在 15 歲以下，65 歲以上的人口不到 4%。 另一方面，在歐洲，65 歲及以上的人口多於 15 歲以下的人口。 2021年，百特國際宣佈在全球推出PrisMax2。 它旨在簡化連續腎臟替代療法和器官支持血漿療法的實施，並提供靈活性以滿足重症監護病房的需求。 PrisMax 2 具有我們的 TrueVue 數字健康產品組合和 PrismaLung 血氣交換器，可提供體外 decaprulation 治療以支持急性呼吸功能障礙。 然而，血漿蛋白產品的高成本將阻礙整個 2022-2029 年預測期內的市場增長。

全球血漿蛋白產品市場研究考慮的主要區域是亞太地區,北美,歐洲,拉丁美洲和世界其他地區。 由於醫療保健支出增加，北美在收入方面佔據主導地位。 根據 Statista 的數據，北美醫療保健行業預計 2023 年將達到 207,7 億美元，2023 年至 2027 年的年增長率為 12,25%，預計 2027 年市場規模將達到 329,7 億美元，預計將達到美元,

本研究的目的是闡明近年來各個細分市場和國家/地區的市場規模，並預測未來幾年的市場規模。 該報告旨在捕捉被調查國家行業的定性和定量方面的情況。

它還提供了關鍵方面的詳細信息，例如決定市場未來增長的驅動因素和挑戰。 此外，它還包含供利益相關者投資的潛在微觀市場機會，以及對主要參與者的競爭格局和產品供應的深入分析。

內容

第 1 章執行摘要

  • 市場概況
  • 2019-2029 年各細分市場的全球市場估計和預測
    • 血漿蛋白市場，按地區劃分，2019-2029 年
    • 血漿蛋白市場，按產品類型，2019-2029 年
    • 血漿蛋白市場，按應用，2019-2029
  • 主要趨勢
  • 調查方法
  • 調查先決條件

第 2 章全球血漿蛋白市場定義和範圍

  • 調查目的
  • 市場定義和範圍
    • 調查範圍
    • 工業發展
  • 本次調查涵蓋的年份
  • 貨幣兌換率

第3章血漿蛋白產品的全球市場動態

  • 血漿蛋白製品市場影響分析(2019-2029)
    • 市場驅動力
      • 免疫缺陷病的發病率增加
      • 老年人口激增
    • 市場挑戰
      • 血漿蛋白製劑的成本較高
    • 市場機會
      • 製藥公司增加對研發項目的投資

第 4 章全球血漿蛋白市場行業分析

  • 波特 5 力模型
    • 供應商的議價能力
    • 買家的議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭公司之間的敵對關係
  • 波特 5 力模型的未來方法 (2019-2029)
  • 害蟲分析
    • 政治
    • 經濟的
    • 社交
    • 技術
  • 主要投資機會
  • 關鍵成功策略
  • 業內人士的前景
  • 分析師的建議和結論

第 5 章風險評估：COVID-19 的影響

  • 評估 COVID-19 對行業的總體影響
  • COVID-19 之前和 COVID-19 之後的市場情景

第 6 章全球血漿蛋白市場：按產品類型分類

  • 市場概況
  • 全球血漿蛋白產品市場：按產品類型,性能 - 潛力分析
  • 2019-2029 年按產品類型分列的世界血漿蛋白產品市場估算和預測
  • 血漿蛋白產品市場細分分析
    • C1 酯□抑製劑
    • 白蛋白
    • 免疫球蛋白
    • 其他

第 7 章全球血漿蛋白市場：按應用

  • 市場概況
  • 世界血漿蛋白產品市場：按應用,性能 - 潛力分析
  • 2019-2029 年血漿蛋白產品的世界市場估計和預測(按應用)
  • 血漿蛋白產品市場細分分析
    • 遺傳性血管性水腫
    • 血友病
    • Genpatsuseimen Ekifuzensho
    • 其他

第 8 章全球血漿蛋白市場：區域分析

  • 血漿蛋白市場，按地區劃分的市場概況
  • 北美
    • 美國
      • 按產品類型估算和預測，2019 年至 2029 年
      • 按應用分類的估計和預測，2019-2029 年
    • 加拿大
  • 歐洲血漿蛋白市場概況
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 意大利
    • 其他歐洲
  • 亞太地區血漿蛋白市場概況
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 韓國
    • 其他亞太地區
  • 拉丁美洲血漿蛋白市場概況
    • 巴西
    • 墨西哥
    • 其他拉丁美洲地區
  • 世界其他地區

第 9 章衝突信息

  • 頂級市場策略
  • 公司簡介
    • 百特國際
      • 關鍵信息
      • 概覽
      • 財務(僅當數據可用時)
      • 產品概覽
      • 近期趨勢
    • Biotest
    • CSL Behring
    • China Biologics
    • GRIFOLS SA
    • Kedrion
    • Octapharma USA Inc
    • Shire Plc
    • Takeda Pharmaceutical Company Ltd
    • ADMA Biologics Inc

第 10 章研究過程

  • 研究過程
    • 數據挖掘
    • 分析
    • 市場評估
    • 驗證
    • 出版
  • 調查的特點
  • 調查先決條件

Global Plasma Protein Therapeutics Market is valued at approximately USD 27.45 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 7% over the forecast period 2022-2029. Plasma protein therapeutics is a biological medicine made up of plasma. It is a biological substance with a distinct chemical composition depending upon how it was produced and processed. The majority of blood is made up of plasma, contains water, salts, proteins, antibodies, and enzymes. The Plasma Protein Therapeutics market is expanding because of factors such as increasing incidence of immune deficiency disorder and surge in geriatric populations. Its prevalence has progressively increased during the last few years.

Plasma protein therapies are used in the treatment of various chronic, life-threatening, and genetic diseases. Its prevalence has progressively increased during the last few years. According to Statista, plasma demand around the world was expected to increase up to 50 million liters by 2020. Furthermore, in 2020, more than 1018.8 metric tons of albumin were consumed worldwide and projected to reach around 1125.5 metric tons by 2022. It is a global protein generated from blood plasma used for cancer diagnostics and therapies, and Morbus Wilson treatments. It is used mostly for cancer diagnostics and therapies. Another important component driving space is increasing geriatric populations. In 2022, Monaco was the country with the highest percentage of total population that was over the age of 65. Monaco has the oldest population in the world with 36 percent of Japanese over 65. Germany on the other hand has 22 percent of its population being over 65 in 2022. In addition Approximately 25% of the world's population is under 15, while 10% is over 65. The youngest population in the world is found in Africa. Indicating the low life expectancy in many nations, 40% of people on the continent are under the age of 15 and less than 4% are over 65. Contrarily, in Europe, a greater proportion of the population is over 65 than is under 15 years old. Furthermore, in 2021 Baxter International Inc. announced the global launch of PrisMax 2. It is designed to simplify delivery of continuous renal replacement therapy and organ support plasma therapies, while providing flexibility to meet the demands of the intensive care unit . The PrisMax 2 system features the company's TrueVue digital health portfolio, as well as the PrismaLung blood-gas exchanger that delivers extracorporeal carbon dioxide removal therapy to support acute respiratory dysfunction. However, the high cost of Plasma Protein Therapeutics stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Plasma Protein Therapeutics Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the space in terms of revenue, owing to the dominance of increase in healthcare expenditure. According to Statista, the Health Care segment of north America is projected to reach USD 20.77 billion in 2023 and expected to show an annual growth rate of 12.25% in between 2023 to 2027, resulting in a projected market volume of USD 32.97 billion by 2027.Furthermore, Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, and increasing research and development related to plasma protein therapies in the market space.

Major market players included in this report are:

  • Baxter International
  • Biotest
  • CSL Behring
  • China Biologics
  • GRIFOLS, S.A.
  • Kedrion
  • Octapharma USA, Inc
  • Shire Plc
  • Takeda Pharmaceutical Company Ltd
  • ADMA Biologics, Inc

Recent Developments in the Market:

  • In April 2020, Kedrion Biopharma collaborated with Kamada Ltd. For manufacturing, development, and distribution of a human plasma-derived Anti-SARS-CoV-2 (COVID-19) polyclonal immunoglobulin (IgG) product as a potential treatment for COVID-19 patients

Global Plasma Protein Therapeutics Market Report Scope:

  • Historical Data: 2019-2020-2021
  • Base Year for Estimation: 2021
  • Forecast period: 2022-2029
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Product Type, Application, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Product Type:

  • C1 esterase Inhibitors
  • Albumins
  • Immunoglobulins
  • Others

By Application:

  • Hereditary Angioedema
  • Hemophilia
  • Primary Immunodeficiency Disorder
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • RoLA
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Plasma Protein Therapeutics Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Plasma Protein Therapeutics Market, by Product Type, 2019-2029 (USD Billion)
    • 1.2.3. Plasma Protein Therapeutics Market, by Application, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Plasma Protein Therapeutics Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Plasma Protein Therapeutics Market Dynamics

  • 3.1. Plasma Protein Therapeutics Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing incidence of immune deficiency disorders
      • 3.1.1.2. Surge in geriatric populations
    • 3.1.2. Market Challenges
      • 3.1.2.1. High Cost of Plasma Protein Therapeutics
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rising investments in research and development programs by the pharmaceutical companies

Chapter 4. Global Plasma Protein Therapeutics Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. Industry Experts Prospective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Plasma Protein Therapeutics Market, by Product Type

  • 6.1. Market Snapshot
  • 6.2. Global Plasma Protein Therapeutics Market by Product Type, Performance - Potential Analysis
  • 6.3. Global Plasma Protein Therapeutics Market Estimates & Forecasts by Product Type 2019-2029 (USD Billion)
  • 6.4. Plasma Protein Therapeutics Market, Sub Segment Analysis
    • 6.4.1. C1 esterase Inhibitors
    • 6.4.2. Albumins
    • 6.4.3. Immunoglobulins
    • 6.4.4. Others

Chapter 7. Global Plasma Protein Therapeutics Market, by Application

  • 7.1. Market Snapshot
  • 7.2. Global Plasma Protein Therapeutics Market by Application, Performance - Potential Analysis
  • 7.3. Global Plasma Protein Therapeutics Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
  • 7.4. Plasma Protein Therapeutics Market, Sub Segment Analysis
    • 7.4.1. Hereditary Angioedema
    • 7.4.2. Haemophilia
    • 7.4.3. Primary Immunodeficiency Disorder
    • 7.4.4. Others

Chapter 8. Global Plasma Protein Therapeutics Market, Regional Analysis

  • 8.1. Plasma Protein Therapeutics Market, Regional Market Snapshot
  • 8.2. North America Plasma Protein Therapeutics Market
    • 8.2.1. U.S. Plasma Protein Therapeutics Market
      • 8.2.1.1. Product Type breakdown estimates & forecasts, 2019-2029
      • 8.2.1.2. Application breakdown estimates & forecasts, 2019-2029
    • 8.2.2. Canada Plasma Protein Therapeutics Market
  • 8.3. Europe Plasma Protein Therapeutics Market Snapshot
    • 8.3.1. U.K. Plasma Protein Therapeutics Market
    • 8.3.2. Germany Plasma Protein Therapeutics Market
    • 8.3.3. France Plasma Protein Therapeutics Market
    • 8.3.4. Spain Plasma Protein Therapeutics Market
    • 8.3.5. Italy Plasma Protein Therapeutics Market
    • 8.3.6. Rest of Europe Plasma Protein Therapeutics Market
  • 8.4. Asia-Pacific Plasma Protein Therapeutics Market Snapshot
    • 8.4.1. China Plasma Protein Therapeutics Market
    • 8.4.2. India Plasma Protein Therapeutics Market
    • 8.4.3. Japan Plasma Protein Therapeutics Market
    • 8.4.4. Australia Plasma Protein Therapeutics Market
    • 8.4.5. South Korea Plasma Protein Therapeutics Market
    • 8.4.6. Rest of Asia Pacific Plasma Protein Therapeutics Market
  • 8.5. Latin America Plasma Protein Therapeutics Market Snapshot
    • 8.5.1. Brazil Plasma Protein Therapeutics Market
    • 8.5.2. Mexico Plasma Protein Therapeutics Market
    • 8.5.3. Rest of Latin America Plasma Protein Therapeutics Market
  • 8.6. Rest of The World Plasma Protein Therapeutics Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. Baxter International
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. Biotest
    • 9.2.3. CSL Behring
    • 9.2.4. China Biologics
    • 9.2.5. GRIFOLS, S.A.
    • 9.2.6. Kedrion
    • 9.2.7. Octapharma USA, Inc
    • 9.2.8. Shire Plc
    • 9.2.9. Takeda Pharmaceutical Company Ltd
    • 9.2.10. ADMA Biologics, Inc

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Plasma Protein Therapeutics Market, report scope
  • TABLE 2. Global Plasma Protein Therapeutics Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Plasma Protein Therapeutics Market estimates & forecasts by Product Type 2019-2029 (USD Billion)
  • TABLE 4. Global Plasma Protein Therapeutics Market estimates & forecasts by Application 2019-2029 (USD Billion)
  • TABLE 5. Global Plasma Protein Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 6. Global Plasma Protein Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Plasma Protein Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Plasma Protein Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Plasma Protein Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Plasma Protein Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Plasma Protein Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Plasma Protein Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Plasma Protein Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Plasma Protein Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. U.S. Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 17. U.S. Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. Canada Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 19. Canada Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 20. Canada Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. UK Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 22. UK Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 23. UK Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. Germany Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 25. Germany Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 26. Germany Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. France Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 28. France Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 29. France Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. Italy Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 31. Italy Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 32. Italy Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Spain Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 34. Spain Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 35. Spain Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. RoE Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 37. RoE Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 38. RoE Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. China Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 40. China Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 41. China Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. India Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 43. India Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 44. India Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. Japan Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 46. Japan Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 47. Japan Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. South Korea Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 49. South Korea Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 50. South Korea Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. Australia Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 52. Australia Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 53. Australia Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. RoAPAC Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. Brazil Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 58. Brazil Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 59. Brazil Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Mexico Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 61. Mexico Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 62. Mexico Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. RoLA Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 64. RoLA Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 65. RoLA Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. Row Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 67. Row Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 68. Row Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. List of secondary sources, used in the study of global Plasma Protein Therapeutics Market
  • TABLE 70. List of primary sources, used in the study of global Plasma Protein Therapeutics Market
  • TABLE 71. Years considered for the study
  • TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Plasma Protein Therapeutics Market, research methodology
  • FIG 2. Global Plasma Protein Therapeutics Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Plasma Protein Therapeutics Market, key trends 2021
  • FIG 5. Global Plasma Protein Therapeutics Market, growth prospects 2022-2029
  • FIG 6. Global Plasma Protein Therapeutics Market, porters 5 force model
  • FIG 7. Global Plasma Protein Therapeutics Market, pest analysis
  • FIG 8. Global Plasma Protein Therapeutics Market, value chain analysis
  • FIG 9. Global Plasma Protein Therapeutics Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Plasma Protein Therapeutics Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Plasma Protein Therapeutics Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Plasma Protein Therapeutics Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Plasma Protein Therapeutics Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Plasma Protein Therapeutics Market, regional snapshot 2019 & 2029
  • FIG 15. North America Plasma Protein Therapeutics Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Plasma Protein Therapeutics Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia Pacific Plasma Protein Therapeutics Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Plasma Protein Therapeutics Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Plasma Protein Therapeutics Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable